2nd Jul 2012 15:11
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 29 June 2012, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.54 per Ordinary Share, and notional ADSs at a price of $45.37 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2012 to 30 June 2012:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent | 2,321.183 | |
Professor Sir Roy Anderson | 580.296 | |
Dr Stephanie Burns | 454.703 | |
Stacey Cartwright | 322.387 | |
Lawrence Culp | 909.406 | |
Sir Crispin Davis | 2,149.243 | |
Judy Lewent | 227.352 | |
Sir Deryck Maughan | 909.406 | |
Dr Daniel Podolsky | 876.927 | |
Tom de Swaan | 795.220 | |
Sir Robert Wilson | 580.296 | |
The Company and the Non-Executive Directors were informed of these allocations on 2 July 2012.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
2 July 2012
Related Shares:
Glaxosmithkline